POPULARITY
10 episodes with clinical pearls
8 episodes with clinical pearls
7 episodes with clinical pearls
17 episodes with clinical pearls
20 episodes with clinical pearls
5 episodes with clinical pearls
7 episodes with clinical pearls
7 episodes with clinical pearls
4 episodes with clinical pearls
Why does up to 10% of bladder cancer pathology change on expert review, and what does that mean for your intermediate and high-risk patients? In this episode of BackTable, Dr. Bogdana Schmidt interviews urologists Dr. Kristen Scarpato and Dr. Sunil Patel to explore the complexities of diagnosis and risk assessment in non–muscle invasive bladder cancer (NMIBC). They discuss the real-world challenges of pathology interpretation, risk-group assignment, evolving diagnostic tools, and the impact these factors have on treatment decisions and patient outcomes. --- Get the BackTable apphttps://www.backtable.com/app --- This podcast is supported by an educational grant from Johnson & Johnson. --- Timestamps00:00 - Introduction01:02 - Risk Stratification07:22 - Upstaging to High Risk10:06 - Calculators and Patient Education15:22 - Specific Tests Use Cases18:50 - Conflicting Biomarker Results21:36 - Adjunct Tests and Counseling24:03 - Recurrence After Chemo Next Steps27:01 - Escalation Deescalation Balance32:48 - Future Research Priorities35:43 - Biology Based Risk Stratification38:03 - Clinical Pearls and Wrap Up --- More about this episodeThe conversation highlights the heterogeneity of intermediate-risk disease, the role and importance of expert pathology over-reads, and the need to accurately document the risk category for ongoing care. They discuss selective use of urinary and genomic assays and how these tests fit alongside cystoscopy and blue light endoscopy. Practical treatment approaches are reviewed, including when to use intravesical gemcitabine or BCG, managing care during BCG shortages, and balancing escalation versus de-escalation of therapy. Additional topics include strategies for long-term surveillance, upper tract imaging, rising rates of bladder cancer in younger patients, and why thorough TURBT and strong patient-provider communication remain central to optimal management. --- Resources The Memorial Studyhttps://www.mskcc.org/cancer-care/clinical-trials/19-288 The BRIDGE Studyhttps://www.nejm.org/doi/full/10.1056/NEJMoa1501035 --- BackTable Urology is the go-to podcast for urologists, urologic oncologists, and urogynecologists. Download the free BackTable app to get early access to new episodes, cases, and courses curated by physicians in your specialty.► https://www.backtable.com/app
In this episode of the AGD Podcast Series, host George Schmidt, DMD, FAGD, speaks with Charles D. Schlesinger, DDS, FICOI, VP of Clinical Development at Impladent LTD, about the critical role of bone grafting in successful dental implant therapy. Dr. Schlesinger explains why grafting is often necessary to create an ideal foundation for implant placement, reviews the advantages and limitations of various grafting materials, and shares practical insights on treatment planning, healing timelines, and radiographic evaluation. The conversation also explores the science behind alloplastic grafting materials, including OsteoGen® crystals, and discusses applications such as socket preservation, sinus augmentation, and immediate implant placement. Drawing on decades of clinical and educational experience, Dr. Schlesinger offers valuable guidance for clinicians seeking to improve implant outcomes while highlighting emerging innovations and future directions in regenerative dentistry. Dr. Schlesinger graduated with honors from The Ohio State College of Dentistry and completed a General Practice Residency at the Veterans Affairs Medical Center in San Diego, later serving as Chief Resident at the Veterans Affairs Medical Center in West Los Angeles, where he received extensive training in oral surgery, implantology, and advanced restorative care.
A guide to diagnosing, imaging, and managing acute renal colic and nephrolithiasis in the ED. Hosts: Brian Gilberti, MD Avir Mitra, MD https://media.blubrry.com/coreem/content.blubrry.com/coreem/Nephrolithiasis.mp3 Download Leave a Comment Tags: Kidney Stones, Urology Show Notes 1. CLINICAL CORE & PHYSIOLOGIC FRAMEWORK Epidemiologic Risk Profiles Lifetime incidence parameters hover around 1 in 11, presenting with a prominent male sex skew. Peak demographic manifestation concentrated within the 30–60 age band. High-yield temporal parameter: 50% recurrence vector within a 5-year post-initial-insult window. Mineralogical Composition Vectors Calcium oxalate crystals represent the predominant structural matrix. Struvite configurations (magnesium ammonium phosphate matrix) account for 1–2% of cohorts. Struvite stones function explicitly as infection-driven configurations secondary to upper tract proliferation; higher distribution index noted in female cohorts. Etiological & Modifiable Relational Dynamics Profound systemic dehydration or low baseline fluid throughput states. High-sodium diet structures and heavy animal-protein consumption loads. Positive genetic/familial history variables. Relative risk modulation: Each variable independently operates to expand baseline risk by a factor of 2x to 3x. Pathophysiologic Symptom Complexes Acute, sudden-onset, maximum-intensity (10/10) unilateral flank pain. Classic structural radiation vector tracking downward toward the ipsilateral groin/genitourinary dermatomes. Distinctive behavioral marker: Renal colic pacing/writhing behavior with zero antalgic position availability. Concomitant autonomic triggers: Nausea and emesis manifest in 50% of acute presentations. Physical Exam Discordance Metrics Severe subjective distress contrasted with a characteristically soft, completely non-tender abdominal palpation exam. CVA tenderness is completely variable and lacks reliable negative predictive value. Atypical Presentation Classifications Vague, poorly localized abdominal pain presentations occurring in up to 20% of active cases. Isolated lower urinary tract irritative signs including acute frequency or severe urgency. Incidental & Asymptomatic Dynamics Silent intrarenal or ureteral stones found incidentally. Longitudinal tracking demonstrates up to 33.3% of initially asymptomatic cohorts convert to fully symptomatic renal colic within a multi-year tracking window. 2. EXCLUSION DIAGNOSES & CRITICAL PATHWAY RED FLAGS Vascular Mimics: AAA rupture/expansion. This is a mandatory exclusion pathway in elderly cohorts presenting with acute flank or back pain. Physical tracking requires active exploration for an expansile, pulsatile abdominal mass. Gynecologic Emergencies: Ruptured ectopic pregnancy. Demands universal screening protocols via rapid beta-hCG testing in all female patients of childbearing potential presenting with lower abdominal/pelvic localization. Infectious Upper Tract Decompensation: Acute uncomplicated pyelonephritis. Differentiated via persistent high spikes, high fevers, systemic shaking chills, and profound pyuria. Genitourinary Structural Crises: Acute testicular torsion. Mandates a thorough, explicit scrotal/testicular structural exam if the flank pain radiates into the scrotum. Gastrointestinal and Adnexal Torsional Confounds: Acute appendicitis variants, acute mesenteric/bowel ischemia, and ovarian torsion syndromes. 3. LABORATORY TESTING & PHYSIOLOGIC EVALUATION Urinalysis Interpretation Nuances Microscopic or gross hematuria presents in approximately 66% to 90% of acute cases. Critical Pathological Caveat: Complete absence of hematuria documented in 20% to 33.3% of confirmed, acute obstructing ureteral stones. Diagnostic rule: A pristine urinalysis with zero red blood cells is entirely insufficient to exclude acute ureterolithiasis. Urinary pH as a Composition Clue Consistently low urinary pH parameters (pH < 5.5) point strongly toward a uric acid crystalline composition. Elevated urinary pH parameters (pH > 7.5) indicate the presence of urease-producing microbial pathogens, pointing toward a struvite infection stone. Infectious Screening Metrics Active tracking for marked pyuria, positive leukocyte esterase, and bacterial nitrites to rule out an obstructed, infected upper urinary tract system. BMP Immediate quantification of baseline serum creatinine to establish accurate eGFR values. Targeting detection of post-renal AKI from bilateral obstruction, unilateral obstruction in a single functioning kidney, or severe volume depletion. CBC Evaluation for marked leukocytosis. Physiologic Nuance: Mild-to-moderate white blood cell count elevations frequently represent non-specific stress demargination driven by severe pain and repetitive vomiting. High-grade white blood cell shifts demand immediate exclusion of systemic bacteremia or an infected, obstructed urinary system. Adjunctive Lab Pathways Rapid qualitative urine hCG testing. Reflex urine culture execution whenever urinalysis metrics display significant inflammatory profiles or clinical suspicion of UTI is high. 4. IMAGING MODALITIES & ALGORITHMIC CLINICAL SELECTION Non-Contrast CT Diagnostics Gold standard; diagnostic sensitivity and specificity parameters exceed 95% for stones >2 mm. Provides precise quantification of stone diameter (mm), exact localization (proximal, mid, or distal ureter), and degree of secondary hydronephrosis. Excellent structural visualization for detecting or ruling out alternate retroperitoneal, vascular, or intra-abdominal pathologies. Contrast-Enhanced CT Protocols Indicated when alternative intra-abdominal surgical pathology is highly suspected over isolated renal colic. Retains diagnostic capability to identify urinary tract stones >3 mm even within contrast-enhanced phases. NCCT Structural Architecture Limitations Standard stone protocol CT scans are executed in a prone position without IV contrast enhancement. It does not opacify the ureteral lumen. Presents a cumulative radiation exposure penalty when utilized serially across recurrent ED presentations. POCUS / Radiology Ultrasound Direct stone visualization capabilities are modest, operating at approximately 50% to 60% sensitivity, and is highly dependent on anatomical positioning at the extreme proximal ureter or the UVJ. Secondary obstruction tracking: Demonstration of hydronephrosis operates at a high sensitivity of approximately 80%. POCUS Clinical Utility Metrics Eliminates ionizing radiation exposure and allows immediate, rapid real-time execution directly at the patient’s bedside. Confirmation of significant hydronephrosis within a classic clinical presentation yields high post-test probability for stone presence while lowering suspicion for vascular catastrophes like a AAA. KUB Radiography Extremely poor overall diagnostic sensitivity, hovering around 57%. Fails to image radiolucent configurations (pure uric acid matrices) or small stones measuring
The American College of Obstetricians and Gynecologists (ACOG) does not recommend routine ultrasound measurement of the lower uterine segment (LUS) thickness as part of the evaluation for trial of labor after cesarean delivery (TOLAC). ACOG Practice Bulletin No. 205 (2019) on Vaginal Birth After Cesarean Delivery does not include LUS measurement among its recommendations for TOLAC candidacy assessment. The guideline focuses on clinical factors such as type of prior uterine incision, number of prior cesarean deliveries, and other obstetric history to determine TOLAC candidacy, and emphasizes that most women with one previous low-transverse cesarean delivery should be counseled about and offered TOLAC. But what if you find a likely uterine window at the LUS? Does that mandate a repeat C-section? This topic comes from Serena, one of our podcast family members. Listen in for details. 1. Dr. Chapa's Clinical Pearls, Dec 31., 2023: LUST FOR TOLAC; and follow up episode Jan 15, 20242. ACOG Practice Bulletin No. 205: Vaginal Birth After Cesarean Delivery. Committee on Practice Bulletins—Obstetrics Obstetrics and Gynecology. 2019;133(2):e110-e127. doi:10.1097/AOG.0000000000003078.3. Rozenberg P, Sénat MV, Deruelle P, et al. Evaluation of the Usefulness of Ultrasound Measurement of the Lower Uterine Segment Before Delivery of Women With a Prior Cesarean Delivery: A Randomized Trial. American Journal of Obstetrics and Gynecology. 2022. 4. Swift BE, Shah PS, Farine D. Sonographic Lower Uterine Segment Thickness After Prior Cesarean Section to Predict Uterine Rupture: A Systematic Review and Meta-Analysis. Acta Obstetricia Et Gynecologica Scandinavica. 2019. 5. McLeish SF, Murchison AB, Smith DM, et al. Predicting Uterine Rupture Risk Using Lower Uterine Segment Measurement During Pregnancy With Cesarean History: How Reliable Is It? A Review. Obstetrical & Gynecological Survey. 2023. 6. Jastrow N, Demers S, Chaillet N, et al. Lower Uterine Segment Thickness to Prevent Uterine Rupture and Adverse Perinatal Outcomes: A Multicenter Prospective study.7. American Journal of Obstetrics and Gynecology. 2016. 8. Guerby P, Bujold E, Chaillet N. Impact of Third-Trimester Measurement of Low Uterine Segment Thickness and Estimated Fetal Weight on Perinatal Morbidity in Women With Prior Cesarean Delivery. Journal of Obstetrics and Gynaecology Canada. JOGC. 2022.
Clinical Pearls, Pain Pod edition: Pain Pearls Part 2 (of many) with Dr. Sing Ping Chow, PharmD as we discuss methadone, buprenorphine, gabapentin, pain pharmacists, AI, and beyond! A cornucopia of pain conundrums and potential solutions and/or tools to help mitigate. All here, nicely packaged, randomly, in one episode of the Pain Pod! One of many more to come, in a miniseries titled: “Pain Pearls”, only here on the Pain Pod! Come one, come all, to the Pain Pod!!! P.S. Want to contribute or hear about a pain pearl of your own? Message Pain Guy on www.painguy.us or LinkedIn to directly reach Mark and have your voice heard!
Clinical Pearls, Pain Pod edition: Pain Pearls Part 2 (of many) with Dr. Sing Ping Chow, PharmD as we discuss methadone, buprenorphine, gabapentin, pain pharmacists, AI, and beyond! A cornucopia of pain conundrums and potential solutions and/or tools to help mitigate. All here, nicely packaged, randomly, in one episode of the Pain Pod! One of many more to come, in a miniseries titled: “Pain Pearls”, only here on the Pain Pod! Come one, come all, to the Pain Pod!!! P.S. Want to contribute or hear about a pain pearl of your own? Message Pain Guy on www.painguy.us or LinkedIn to directly reach Mark and have your voice heard!
Hosts: Dr. Daniel Ennis, Dr. Janet PopeGuest: Dr. Marinka Twilt (Pediatric Rheumatologist, University of Calgary; ASM Program Committee Chair)We're coming to you almost live from Halifax for Day 1 of the Canadian Rheumatology Association ASM. The day featured key updates across the field, including gaps in pediatric trials, growing recognition of autoinflammatory diseases, and the expanding role of genetics.The SELECT-GCA trial reinforced that upadacitinib is effective for both induction and maintenance of Giant Cell Arteritis (GCA), with high relapse rates after stopping—supporting longer-term treatment. In pediatric ANCA vasculitis, rituximab showed similar efficacy to cyclophosphamide with a safer profile.Sessions on “tough-to-treat RA” highlighted how often non-inflammatory factors drive symptoms, while Clinical Pearls and Medical Mysteries emphasized revisiting diagnoses and the importance of pathology and genetics.The keynote by Dr. Elizabeth Volkman rounded out the day with a focus on holistic care and patient empowerment. Main TakeawaysGCA likely requires longer-term therapy to prevent relapseRituximab is a safe, effective alternative in pediatric ANCA vasculitis“Tough-to-treat RA” often reflects non-inflammatory diseaseReassess when treatments fail—diagnosis evolvesGenetics and pathology are increasingly central to complex casesHolistic care and patient empowerment matter for outcomesWhat to Watch on Day 2New myositis insights, including statin-associated diseasePodium presentations showcasing emerging researchHands-on workshops (including TMJ)Poster tours, with a focus on trainee workThe Great Debate: “Be it resolved that medications should be tapered in patients with inflammatory arthritis in remission.”More highlights coming tomorrow—stay tuned!
The Real Truth About Health Free 17 Day Live Online Conference Podcast
Dr. Marbas explains white cells, platelets, MCV, and iron trends—debunking common misinterpretations in healthy plant-based labs. #LabInterpretation #VeganLabs #B12Deficiency #IronHealth
For this week's episode of the Clinician's Corner, we've gone into the archives to pull out another clinical pearl from one of our favorite episodes – a fascinating conversation with our beloved Medical Director, Dr. Chris Turnpaugh, where we discuss chronic infections, immune dysregulation, and detox strategies. This interview first aired early last year (2025), and the full interview can be viewed here. Clinical pearls we extracted from the original interview: Overview of chronic infections and the immune system The role of environmental toxins on the immune system/immune response Addressing toxic burden and supporting detoxification Various therapeutic interventions Lyme disease and Long Covid (and other complex client cases) Foundational immune support The Clinician's Corner is brought to you by the Institute of Restorative Health. Follow us: https://www.instagram.com/instituteofrestorativehealth/ Connect with Dr. Chris Turnpaugh: Website: TurnpaughHWC.comFacebook: https://www.facebook.com/TurnpaughHWC/ Instagram: TurnpaughHealth Timestamps: 00:00 TH1 vs. TH2 Immunity Explained 03:32 "Reducing Toxic Burden Strategies" 08:19 "NAC: The Ultimate Supplement" 11:09 "Master Clinical Skills, Transform Lives" Speaker bio: Dr. Chris Turnpaugh is a practitioner and CEO at Turnpaugh Health, a Functional Medicine wellness center, which he founded in 1999. The center, one of the largest in the country, has grown to over 20 healthcare providers and a team of more than 50 in five locations. Turnpaugh Health provides in-depth holistic care focusing on functional medicine, investigating the mechanisms of dysfunction in patients. The clinic also provides integrative family medicine, lifestyle medicine, and many complementary wellness services. Over his twenty years in practice, Dr. Turnpaugh has joined ILADS and is known as a thought leader in Lyme disease and associated co-infections. He also traveled to Lake Como to participate on the PANDAS International board. He has a deep interest and extensive knowledge in pediatric neurological disorders and methods of supporting these children holistically. Dr. Turnpaugh has lectured on a broad variety of health topics, both nationally and internationally. His application of functional medicine as it relates to the neuro/endocrine/immune systems is a unique clinical approach to non-pharmacological treatments. He is well respected among his peers and patients as a provider and functional medicine instructor. He has treated thousands of patients in his practice and mentored hundreds of practitioners. His true passion is teaching functional medicine to other practitioners and helping patients to optimize their health. Keywords: functional health practitioners, clinical skills, chronic disease, restoring balance, chronic infections, immune system, TH1, TH2 dominance, autoimmunity, cancer, chemicals, pesticides, endocrine disrupting compounds, toxic burden, gut symptoms, liver, bile flow, digestion, nutrient supplementation, detoxification, sauna therapy, nasal spray, peptide therapy, liposomal glutathione, NAC, vitamin D, immune dysregulation, long Covid, post-treatment Lyme disease, food intolerances, chemical sensitivities, microbiome Disclaimer: The views expressed in the IRH Clinician's Corner series are those of the individual speakers and interviewees, and do not necessarily reflect the views of the Institute of Restorative Health, LLC. The Institute of Restorative Health, LLC does not specifically endorse or approve of any of the information or opinions expressed in the IRH Clinician's Corner series. The information and opinions expressed in the IRH Clinician's Corner series are for educational purposes only and should not be construed as medical advice. If you have any medical concerns, please consult with a qualified healthcare professional. The Institute of Restorative Health, LLC is not liable for any damages or injuries that may result from the use of the information or opinions expressed in the IRH Clinician's Corner series. By viewing or listening to this information, you agree to hold the Institute of Restorative Health, LLC harmless from any and all claims, demands, and causes of action arising out of or in connection with your participation. Thank you for your understanding.
This episode is a REPLAY of one of the most popular Physio Explained episodes we've ever released, originally launched on the 6th of October 2021. In this episode with Jill Cook we explore:The tendon continuum model and tendon pathophysiology based on current researchWhat is clinically relevant for patient careHow to progress a real caseChallenging the idea of “just loading a tendon heavy and slow”Practical tips on measuring tendon load, not just pain
This bonus episode is a quick-fire collection of clinical pearls drawn from across the St Emlyn's podcast in 2025. Short, practical, and deliberately focused, these are the moments that make you stop and think: “That's useful — I want that in my head.” There's minimal commentary and no deep dives. Each clip stands on its own as a clear takeaway, designed to be listened to in one go or dipped back into when needed. In this episode Practical triage language that lowers thresholds and prompts earlier action Time-critical decision-making in pre-hospital thoracotomy Resuscitation physiology and why diastolic pressure matters Intraosseous access and the reality of long-term complications Analgesia strategies for rib fractures, including posterior injuries Hydrofluoric acid burns and why improvised treatment is a trap Recognising and acting on decompression illness Cognitive HALOs and preparing for rare, high-load decision moments Building excellence in teams, not just avoiding failure Compassionate resuscitation and the value of the pause This episode is designed to be saved, revisited, and shared — the kind of learning that pays off later. Featured episodes Clips in this episode are taken from the following full St Emlyn's episodes: Episode 257 — Ten Second Triage with Sean Brayford-Harris Episode 270 — Insights on Cannabis Edibles, Pre-Hospital Thoracotomy and more Episode 266 — Monthly Round Up (February 2025): Skills Fade and Resuscitation Targets Episode 260 — Monthly Round Up (December 2024): IO Access and Chest Trauma Episode 268 — Top Papers of 2024 from The Big Sick Conference Episode 275 — Targeted Resuscitation and Hydrofluoric Acid Burns Episode 263 — Hyperbaric Medicine with Jeff Kerrie Episode 277 — Cognitive HALOs and Advanced Simulation Training Episode 264 — High Performance Teams with Dan Dworkis Episode 258 — Compassionate Resuscitation with Matt Hooper All full episodes are available in the podcast feed. About MedPod Learn MedPod Learn is a medical podcast player designed to help turn listening into structured learning, with tools to support reflection, CPD, and appraisal. Available on the App Store and Google Play.
Ketamine is a dissociative anesthetic that provides powerful analgesia while preserving spontaneous ventilation, airway reflexes, and sympathetic tone, which makes it especially valuable in trauma, bronchospasm, difficult airways, and in patients with high opioid tolerance. As a phencyclidine derivative with a chiral center, it exists as two enantiomers, with S-ketamine roughly twice as potent as R-ketamine and associated with fewer unpleasant emergence reactions, while its pKa and balanced water–lipid solubility allow rapid CNS penetration and redistribution-limited offset. Its multimodal mechanism centers on noncompetitive NMDA antagonism but also includes opioid receptor modulation, catecholamine reuptake inhibition, AMPA receptor effects, ion channel blockade, muscarinic antagonism, and anti-inflammatory actions, all of which underpin clinical dosing strategies for induction, maintenance, procedural sedation, and analgesic infusions as well as key considerations around emergence delirium, secretions, cardiovascular status, and ICP.Want to learn more? Grab our Cardiac Pharm Course --> [HERE]⚛️ CONNECT:
For this week's episode of the Clinician's Corner, we've gone into the archives to pull out another clinical pearl from one of our favorite episodes - and today we discuss beta glucuronidase and its surprisingly wide-ranging impact on our health (from hormones to gut health and even bone health). This interview first aired earlier this year (2025), and the full interview can be viewed here. Clinical pearls we extracted from the original interview: Understanding beta-glucuronidase (what it is and what it does) Challenging established views on beta glucuronidase Hormone-microbiome interactions Beta glucuronidase and GI function Clinical implications for women Gut-healing supplement recommendations The Clinician's Corner is brought to you by the Institute of Restorative Health. Follow us: https://www.instagram.com/instituteofrestorativehealth/ Connect with Dr. Betty Murray: Websites: https://bettymurray.com; https://livingwelldallas.com; and https://getmenrva.com YouTube: https://www.youtube.com/@drbettymurray and https://www.youtube.com/@MenopauseMasteryShow Instagram: https://www.instagram.com/drbettymurray/ Facebook: https://www.facebook.com/drbettymurray LinkedIn: https://www.linkedin.com/in/bettymurray/ Timestamps: 00:00 "Microbiome Shifts with Hormones" 03:15 Microbiome, Hormones, and IBS Connections 06:26 Hormones, IBS, and Menopause Trends 10:21 "Fermented Foods and Intuition" 13:04 Clinician's Corner: Thank You Speaker bio: Dr. Betty Murray is a women's health advocate, nutrition expert, PhD researcher, certified functional medicine practitioner, author, and speaker. Betty helps women over 40 harness their hormones to lose weight, optimize sleep, restore energy, and thrive. During her research for her Ph.D., Betty made several key discoveries that lead to hormone & metabolic imbalances that plague women over 40. Restoring balance to these key metabolic and hormone pathways is the basis of her Menopause Mastery Program. Dr. Betty is the founder and CEO of Living Well Dallas Functional Medicine Center and Menrva, a national women's telemedicine company providing bioidentical hormone treatment, nutrition, diet, and lifestyle guidance to feel like perimenopause and menopause never happened. She is the host of the Menopause Mastery Podcast, author, and featured writer for Brainz Magazine. As a professional speaker, she has shared the stage with Lisa Nichols, Dr. Mark Hyman, JJ Virgin, Dr. Steven Gundry, Codie Sanchez, Dr. Shrini Pallay, and many others, and she is a frequently featured nutrition expert on Fox News Broadcasting, CW33, NBC, and CBS. Keywords: functional health practitioners, beta glucuronidase, gut health, hormones, estrogen metabolism, microbiome, menopause, perimenopause, chronic disease, stool testing, IBS (Irritable Bowel Syndrome), serotonin receptors, neurotransmitters, glucuronidation, prostaglandins, GI motility, hormone cycles, case studies, evidence-based strategies, clinical pearls, hormone receptors, digestive supplements, fermented foods, polyphenols, resistant starches, gut healing protocols, 5R protocol, clinical training, restorative health, women's health Disclaimer: The views expressed in the IRH Clinician's Corner series are those of the individual speakers and interviewees, and do not necessarily reflect the views of the Institute of Restorative Health, LLC. The Institute of Restorative Health, LLC does not specifically endorse or approve of any of the information or opinions expressed in the IRH Clinician's Corner series. The information and opinions expressed in the IRH Clinician's Corner series are for educational purposes only and should not be construed as medical advice. If you have any medical concerns, please consult with a qualified healthcare professional. The Institute of Restorative Health, LLC is not liable for any damages or injuries that may result from the use of the information or opinions expressed in the IRH Clinician's Corner series. By viewing or listening to this information, you agree to hold the Institute of Restorative Health, LLC harmless from any and all claims, demands, and causes of action arising out of or in connection with your participation. Thank you for your understanding.
In this episode, Sam Ashoo, MD and T.R. Eckler, MD discuss the November 2025 Emergency Medicine Practice article, Diagnosis and Management of Emergency Department Patients With Alcohol Withdrawal SyndromeEpidemiology & Background Rising ED visits related to alcohol use. Mortality rates and spectrum of patient presentations. Importance of high suspicion and complexity of cases.Pathophysiology & Mechanisms Alcohol metabolism and neurochemical changes. Differential diagnosis: Conditions that mimic alcohol withdrawal.Prehospital & EMS Considerations Role of EMS in triage and initial management. Use of sobering centers vs. ED transport. Prehospital administration of benzodiazepines (IM midazolam).History & Risk Assessment Key questions to assess risk for alcohol withdrawal syndrome. Importance of patient history, medication use, and comorbidities. Discussion on patient honesty and rapport.Physical Exam & Scoring Systems DSM-5 criteria for alcohol withdrawal. Use of CIWA-AR, BAWS, and PAWSS scoring systems. Importance of objective measurement for monitoring and disposition.Complications & Special PresentationsComplicated alcohol withdrawal: Hallucinosis, seizures, delirium tremens. Diagnostic workup: Labs, imaging, and co-ingestions. Special populations: End-stage liver disease, pregnancy, intubated patients.Treatment Strategies Mainstay: Benzodiazepines (types, dosing, and protocols). Phenobarbital: Indications, dosing, and evidence. Adjunctive therapies: Thiamine, glucose, magnesium. Alternative/adjunct medications: Gabapentin, ketamine, dexmedetomidine, baclofen.Clinical Pearls & Practice Changes Early, aggressive therapy to prevent complications. Symptom-based vs. fixed-schedule treatment. Gabapentin as an alternative or adjunct. Anti-craving medications for relapse prevention.Disposition & Protocols Use of scoring systems for safe discharge, observation, or admission. Importance of protocolized approaches and community resources.Summary & Take-Home Points Five key practice-changing points. Clinical pathway.Emergency Medicine Residents, get your free subscription by writing resident@ebmedicine.net
For this week's episode of the Clinician's Corner, we've gone into the archives to pull out another clinical pearl from one of our favorite episodes - and today we discuss the powerful healing properties of sulforaphane with David Roberts & Dr. John Gildea, from Mara Labs. This interview first aired in 2023, and the full interview can be viewed here. Clinical pearls we extracted from the original interview: The story behind BrocElite, a stabilized sulforaphane supplement The motivation behind the research The scientific background on sulforaphane (e.g., its development and stabilization) How sulforaphane plays a role in cancer and chemotherapy The Clinician's Corner is brought to you by the Institute of Restorative Health. Follow us: https://www.instagram.com/instituteofrestorativehealth/ Connect with Mara Labs: Website: https://mara-labs.com/ Instagram: https://www.instagram.com/themaralabs/?hl=en Facebook: https://www.facebook.com/themaralabs/ Speaker bios: David Roberts holds a MPH from Johns Hopkins, a Masters in BME from the UVA, and a Bachelors in EE and BME from Duke. David has more than 20 years of public health experience on three continents. In 2014 David cofounded the gut supplement, RESTORE, now called ION. Dr. John Gildea is Cell Pathophysiologist and Molecular Geneticist with 33 years of scientific research experience at the bench in both industrial and academic labs. A guiding principle of his work is to establish innovative optimized model systems and assays in order to robustly investigate both normal and pathological states. He has extensive expertise establishing and investigating in-vivo, ex-vivo, primary and immortalized cell culture systems, molecular biology, antibody based and nucleic acid based diagnostic assay development, electron and fluorescence microscopy and flow cytometry. Dr. Gildea has published 63 peer reviewed articles, 3 book chapters, 3 reviews, 3 patents, and has 3173 citations. Keywords: functional health, sulforaphane, broccoli, breast cancer, oncology, chemosensitizer, glucoraphanin, myrosinase, supplement, restorative health, anti cancer, clinical skills, chronic disease, cancer models, NRF2, antioxidant system, chemotherapy, metastasis, Mara Labs, Baroque Elite, broccoli sprouts, juicing, practitioner training, case studies, gastrointestinal healing, functional medicine, curriculum, certification, clinical mastery, immune system, detoxification Disclaimer: The views expressed in the IRH Clinician's Corner series are those of the individual speakers and interviewees, and do not necessarily reflect the views of the Institute of Restorative Health, LLC. The Institute of Restorative Health, LLC does not specifically endorse or approve of any of the information or opinions expressed in the IRH Clinician's Corner series. The information and opinions expressed in the IRH Clinician's Corner series are for educational purposes only and should not be construed as medical advice. If you have any medical concerns, please consult with a qualified healthcare professional. The Institute of Restorative Health, LLC is not liable for any damages or injuries that may result from the use of the information or opinions expressed in the IRH Clinician's Corner series. By viewing or listening to this information, you agree to hold the Institute of Restorative Health, LLC harmless from any and all claims, demands, and causes of action arising out of or in connection with your participation. Thank you for your understanding.
Jackie Garlich, OD, FAAO, and Jessilin Quint, OD, MS, MBA, FAAO, welcome Alfonso L. Sabater, MD, PhD, on this episode of To the Point to share his expertise on the use of autologous serum drops in the treatment of ocular surface and corneal disease. Dr. Sabater describes some of the clinical benefits and challenges, which patients may be ideal candidates, and what clinicians should know when getting started with this treatment option.
Bridge the gap between innovation and practice: are you unlocking the potential of novel agents in dialysis-dependent chronic kidney disease (CKD) anemia? Credit available for this activity expires: 10/31/26 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1003063?ecd=bdc_podcast_libsyn_mscpedu
Stubborn Candida Signs That Secretly Sabotage Your Body - Clinical Pearls Discussed
For this week's episode of the Clinician's Corner, we've gone into the archives to pull out another clinical pearl from one of our favorite episodes - and today we discuss glutathione's role in detox, inflammation, and client care with Dr. Gina Nick. This interview first aired in 2024, and the full interview can be viewed here. Clinical pearls we extracted from the original interview: Dr. Gina's personal health journey and observations of people benefiting from detox Her discovery and clinical use of glutathione (including its use during Covid and with drug addiction) The science and mechanisms of glutathione (e.g., glutathione as "master antioxidant") Dosing and timing considerations Practical uses in everyday scenarios The Clinician's Corner is brought to you by the Institute of Restorative Health. Follow us: https://www.instagram.com/instituteofrestorativehealth/ Connect with Dr. Gina Nick: Website: www.bestdailyever.com Instagram: @bestdailyever and @drginanick Facebook: bestdailyever and drginahealing Twitter: @bestdailyever and @drginanick Timestamps: 00:00 "Glutathione: Master Antioxidant Insights" 05:56 "Mitochondrial Toxins and Cognitive Decline" 09:41 Gastrointestinal Healing Self-Study Launch 11:27 "Begin Your Restorative Health Journey" Speaker bio: Dr. Gina Nick is a world-renowned Naturopathic Physician, Researcher, and Formulator based in Newport Beach, California. With a dedication to holistic wellness, she's known for her expertise in treating a wide range of health concerns, from autoimmune diseases to addiction recovery, anxiety, and more. After graduation from medical school, she became the Director of Research for a leading supplement company, earning the company billions. She's since held the roles of Executive Healthcare Consultant to Local and Government Agencies and President Emeritus of the California Naturopathic Doctors Association. As the Founder and Director of Healthbridge in Newport Beach, California, her practice was awarded "Top Medical Practice 2017," a testament to her commitment to excellence. As a published author, entrepreneur, and certified yoga instructor, Dr. Gina is a multifaceted professional with a passion for improving the lives of others. With her unwavering commitment to nurturing health naturally, she's not just your typical medical professional. Dr. Gina is a nurturing soul, a devoted mom, and an advocate for holistic well-being. She's licensed in both California and Hawaii and is excited to share her journey with you. Disclaimer: The views expressed in the IRH Clinician's Corner series are those of the individual speakers and interviewees, and do not necessarily reflect the views of the Institute of Restorative Health, LLC. The Institute of Restorative Health, LLC does not specifically endorse or approve of any of the information or opinions expressed in the IRH Clinician's Corner series. The information and opinions expressed in the IRH Clinician's Corner series are for educational purposes only and should not be construed as medical advice. If you have any medical concerns, please consult with a qualified healthcare professional. The Institute of Restorative Health, LLC is not liable for any damages or injuries that may result from the use of the information or opinions expressed in the IRH Clinician's Corner series. By viewing or listening to this information, you agree to hold the Institute of Restorative Health, LLC harmless from any and all claims, demands, and causes of action arising out of or in connection with your participation. Thank you for your understanding.
Elevate your nasopharyngeal cancer (NPC) care. Top experts deliver 10 clinical pearls on new standards in immunotherapy, radiation, and surveillance. Credit available for this activity expires: 9/30/26 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/top-10-clinical-pearls-outlining-optimal-care-nasopharyngeal-2025a1000pwu?ecd=bdc_podcast_libsyn_mscpedu
For this week's episode of the Clinician's Corner, we've gone into the archives to pull out another clinical pearl from one of our favorite episodes - and today we discuss bone health with Kevin Ellis, the Bone Coach. This interview first aired in 2024, and the full interview can be viewed here. Clinical pearls we extracted from the original interview: - The importance of comprehensive bone assessment (such as using the Trabecular Bone Score (TBS) as a measure of bone quality. - Understanding osteoporosis, including categories of osteoporosis and the key factors leading to osteoporosis - Types of bone assessment tools - Building and maintaining bone health - Practical guidelines for supplementation and nutrition The Clinician's Corner is brought to you by Restorative Wellness Solutions. Follow us: https://www.instagram.com/restorativewellnesssolutions/ Connect with Kevin Ellis: BoneCoach™ Website: https://bonecoach.com/ BoneCoach™ Facebook: https://www.facebook.com/bonecoach BoneCoach™ Youtube: https://www.youtube.com/bonecoach BoneCoach™ Instagram: https://www.instagram.com/bonecoachkevin BoneCoach™ Pinterest: https://www.pinterest.com/bonecoach BoneCoach™ TikTok: https://www.tiktok.com/@bonecoach BoneCoach™ Podcast: https://podcasts.apple.com/us/podcast/the-bone-coach-osteoporosis-bone-health-podcast/id1483975147 BoneCoach™ Linkedin: https://www.linkedin.com/in/bonecoach Timestamps: 00:00 Bone Health Insights for Clinicians 06:16 "Essential Vitamins for Bone Health" 08:18 "Master Gut Healing Course" Speaker bio: Kevin Ellis, better known as Bone Coach™, is a Forbes-featured Integrative Health Coach, podcaster, and is the founder of BoneCoach.com Through a unique 3-step process and a world-class coaching program called the Stronger Bones Solution™, he and his team have helped thousands of people with osteopenia and osteoporosis in over 1500+ cities around the world get confident in their stronger bones plan. His mission is to help millions of people with osteoporosis build stronger bones… and to help our children and grandchildren create a strong and healthy foundation so they can lead long, active lives. Keywords: osteoporosis, bone density, bone quality, trabecular bone score, TBS, bone strength, early screening, baseline bone scans, bone health, functional health professionals, bone formation, bone loss, fracture risk, DEXA scan, hormone balance, resistance training, calcium intake, calcium supplementation, vitamin K2, vitamin D, magnesium, digestive health, postmenopausal women, estrogen, primary osteoporosis, secondary osteoporosis, glucocorticoids, prednisone, kidney stones, cardiovascular disease risk Disclaimer: The views expressed in the RWS Clinician's Corner series are those of the individual speakers and interviewees, and do not necessarily reflect the views of Restorative Wellness Solutions, LLC. Restorative Wellness Solutions, LLC does not specifically endorse or approve of any of the information or opinions expressed in the RWS Clinician's Corner series. The information and opinions expressed in the RWS Clinician's Corner series are for educational purposes only and should not be construed as medical advice. If you have any medical concerns, please consult with a qualified healthcare professional. Restorative Wellness Solutions, LLC is not liable for any damages or injuries that may result from the use of the information or opinions expressed in the RWS Clinician's Corner series. By viewing or listening to this information, you agree to hold Restorative Wellness Solutions, LLC harmless from any and all claims, demands, and causes of action arising out of or in connection with your participation. Thank you for your understanding.
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/AAPA information, and to apply for credit, please visit us at PeerView.com/EFP865. CME/MOC/NCPD/AAPA credit will be available until August 20, 2026.Leveraging Biomarkers to Optimize Treatment Outcomes With ATTs in Early Symptomatic Alzheimer's Disease: New Data and Clinical Pearls From AAIC 2025 In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Lilly.Disclosure information is available at the beginning of the video presentation.
PeerView Neuroscience & Psychiatry CME/CNE/CPE Audio Podcast
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/AAPA information, and to apply for credit, please visit us at PeerView.com/EFP865. CME/MOC/NCPD/AAPA credit will be available until August 20, 2026.Leveraging Biomarkers to Optimize Treatment Outcomes With ATTs in Early Symptomatic Alzheimer's Disease: New Data and Clinical Pearls From AAIC 2025 In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Lilly.Disclosure information is available at the beginning of the video presentation.
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/AAPA information, and to apply for credit, please visit us at PeerView.com/EFP865. CME/MOC/NCPD/AAPA credit will be available until August 20, 2026.Leveraging Biomarkers to Optimize Treatment Outcomes With ATTs in Early Symptomatic Alzheimer's Disease: New Data and Clinical Pearls From AAIC 2025 In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Lilly.Disclosure information is available at the beginning of the video presentation.
PeerView Neuroscience & Psychiatry CME/CNE/CPE Video Podcast
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/AAPA information, and to apply for credit, please visit us at PeerView.com/EFP865. CME/MOC/NCPD/AAPA credit will be available until August 20, 2026.Leveraging Biomarkers to Optimize Treatment Outcomes With ATTs in Early Symptomatic Alzheimer's Disease: New Data and Clinical Pearls From AAIC 2025 In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Lilly.Disclosure information is available at the beginning of the video presentation.
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/AAPA information, and to apply for credit, please visit us at PeerView.com/EFP865. CME/MOC/NCPD/AAPA credit will be available until August 20, 2026.Leveraging Biomarkers to Optimize Treatment Outcomes With ATTs in Early Symptomatic Alzheimer's Disease: New Data and Clinical Pearls From AAIC 2025 In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Lilly.Disclosure information is available at the beginning of the video presentation.
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/AAPA information, and to apply for credit, please visit us at PeerView.com/EFP865. CME/MOC/NCPD/AAPA credit will be available until August 20, 2026.Leveraging Biomarkers to Optimize Treatment Outcomes With ATTs in Early Symptomatic Alzheimer's Disease: New Data and Clinical Pearls From AAIC 2025 In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Lilly.Disclosure information is available at the beginning of the video presentation.
For this week's episode of the Clinician's Corner, we've gone into the archives to pull out another clinical pearl from one of our favorite episodes - and today we discuss the gut-brain connection with Kiran Krishnan. This interview first aired back in 2023, and the full interview can be viewed here. Clinical pearls we extracted from the original interview: - The prevalence and and connection of key health issues with the gut (such as IBS, depression, and anxiety) - The psychology behind learning to live with chronic health issues - The science behind psychobiotics (specifically looking at Bifidobacterium longum 1714 - its anti-inflammatory properties and impact on mood & brain activity) - Practical takeaways for clinicians (such as how to use these psychobiotics to prevent leaky-gut, modulate stress, and reduce inflammation). The Clinician's Corner is brought to you by Restorative Wellness Solutions. Follow us: https://www.instagram.com/restorativewellnesssolutions/ Connect with Kiran Krishnan: Website: https://microbiomelabs.com/ Instagram: https://www.instagram.com/kiranbiome/ Timestamps: 00:00 Widespread Self-Medication for Common Ailments 05:56 Brain Scan Study: Placebo vs. 1714 09:15 "Master Gut Healing for Clinicians" 10:18 "Effective Gut Health Protocols" Speaker bio: Kiran Krishnan has been involved in the dietary supplement and nutrition market for the past 17 years. Coming from a strict research background, working for years in the product development for Amano Enzyme, USA - one of the world's largest suppliers of therapeutic enzymes - he has designed and conducted dozens of human clinical trials in human nutrition. And now he holds the title of Chief Scientific Officer at Physician's Exclusive and Microbiome Labs. Kiran has developed over 50 private label nutritional products for small to large brands in the global market, is a frequent lecturer on the Human Microbiome at Medical and Nutrition Conferences, and is currently involved in 9 novel human clinical trials on probiotics and the human microbiome. Keywords: Restorative Wellness Solutions, functional health professionals, gut-brain connection, Kiran Krishnan, Microbiome Labs, probiotics, psychobiotic, Bifidobacterium longum 1714, gut health, brain health, inflammation, mood improvement, anxiety, depression, irritable bowel syndrome (IBS), gut inflammation, microbiome, cortisol, HPA axis, neurotransmitters, stress response, food sensitivities, gastrointestinal healing, advanced lab testing, chronic illness, constipation, diarrhea, food intolerances, sleep disorders, practitioner training, clinical protocols Disclaimer: The views expressed in the RWS Clinician's Corner series are those of the individual speakers and interviewees, and do not necessarily reflect the views of Restorative Wellness Solutions, LLC. Restorative Wellness Solutions, LLC does not specifically endorse or approve of any of the information or opinions expressed in the RWS Clinician's Corner series. The information and opinions expressed in the RWS Clinician's Corner series are for educational purposes only and should not be construed as medical advice. If you have any medical concerns, please consult with a qualified healthcare professional. Restorative Wellness Solutions, LLC is not liable for any damages or injuries that may result from the use of the information or opinions expressed in the RWS Clinician's Corner series. By viewing or listening to this information, you agree to hold Restorative Wellness Solutions, LLC harmless from any and all claims, demands, and causes of action arising out of or in connection with your participation. Thank you for your understanding.
Top Takeaways from the Coccydynia Symposium (Flash Sale!)We just wrapped the Coccydynia Symposium, bringing together the world's leading experts on persistent tailbone pain.In this episode, Nicole shares her biggest takeaways from each speaker, including:
HIV treatment has evolved significantly, offering streamlined regimens and improved patient outcomes. This episode will discuss the latest antiretroviral therapy (ART) guidelines, highlighting preferred regimens, key pharmacologic considerations, and practical counseling strategies for pharmacists. Tune in to enhance your clinical knowledge and play a pivotal role in optimizing care for individuals living with HIV. Joshua Davis Kinsey, PharmDVP, EducationCEimpactRachel Maynard, PharmDLead EditorPyrlsJoshua Davis Kinsey and Rachel Maynard have no relevant financial relationships to disclose. BONUS: With this episode, you also get exclusive, free access to beautifully designed clinical charts and practice resources from our friends at Pyrls, that you can use in your everyday practice. Click the links below to access these practical tools:HIV PharmacotherapyHIV MedicationsAnd more! Pharmacists, REDEEM YOUR CPE HERE!CPE is available to Health Mart franchise members onlyTo learn more about Health Mart, click here: https://join.healthmart.com/CPE INFORMATION Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:1. Identify current guideline-recommended antiretroviral therapy (ART) regimens and their key components.2. Describe important counseling points for pharmacists supporting patients on HIV treatment, including adherence, side effects, and drug interactions.0.05 CEU/0.5 HrUAN: 0107-0000-25-245-H02-PInitial release date: 7/21/2025Expiration date: 7/21/2026Additional CPE details can be found here.
HIV treatment has evolved significantly, offering streamlined regimens and improved patient outcomes. This episode will discuss the latest antiretroviral therapy (ART) guidelines, highlighting preferred regimens, key pharmacologic considerations, and practical counseling strategies for pharmacists. Tune in to enhance your clinical knowledge and play a pivotal role in optimizing care for individuals living with HIV. Joshua Davis Kinsey, PharmDVP, EducationCEimpactRachel Maynard, PharmDLead EditorPyrlsJoshua Davis Kinsey and Rachel Maynard have no relevant financial relationships to disclose. BONUS: With this episode, you also get exclusive, FREE access to beautifully designed clinical charts and practice resources from our friends at Pyrls, that you can use in your everyday practice. Click the links below to access these practical tools:HIV PharmacotherapyHIV MedicationsAnd more! Pharmacist Members, REDEEM YOUR CPE HERE! Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)CPE INFORMATIONLearning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:1. Identify current guideline-recommended antiretroviral therapy (ART) regimens and their key components.2. Describe important counseling points for pharmacists supporting patients on HIV treatment, including adherence, side effects, and drug interactions. 0.05 CEU/0.5 HrUAN: 0107-0000-25-245-H02-PInitial release date: 7/21/2025Expiration date: 7/21/2026Additional CPE details can be found here.Follow CEimpact on Social Media:LinkedInInstagram
In this episode, we explore buprenorphine management for opioid use disorder, covering induction protocols, dosing strategies, and long-term maintenance. Why do patients need to be in withdrawal before starting this life-saving medication, and how can we make this challenging process more manageable? Faculty: Smita Das, M.D. Host: Richard Seeber, M.D. Learn more about our memberships here Earn 1 CME: Pharmacologic Management of Opioid Use Disorder Buprenorphine for Managing OUD
For this week's episode of the Clinician's Corner, we've gone into the archives to pull out another clinical pearl from one of our favorite episodes - and today we discuss the world of integrative cancer care with Dr. Nasha Winters. This interview first aired back in 2023, and the full interview can be viewed here. Clinical pearls we extracted from the original interview: The “cancer terrain” concept and its drivers (Dr. Nasha highlights the top 10) Diet, nutrition, and cancer The modern state of metabolic health - and misconceptions about metabolic markers The role of ketosis and therapeutic diets in cancer Testing and lab assessment for personalized nutrition Therapeutic ketosis in pediatric cases The Clinician's Corner is brought to you by Restorative Wellness Solutions. Follow us: https://www.instagram.com/restorativewellnesssolutions/ Join us for a FREE 3-Part Fertility Masterclass Series: Precision Nutrition for Fertility Grab your spot now! Connect with Dr. Nasha Winters: Website: https://www.drnasha.com Facebook: https://www.facebook.com/drnashainc/ and https://www.facebook.com/mtih.org Instagram: https://www.instagram.com/drnashawinters/ and https://www.instagram.com/mtihorg LinkedIn: https://www.linkedin.com/in/nasha-winters-796374b6/ Twitter: https://twitter.com/drnashawinters and https://twitter.com/MTIH_Terrain YouTube: https://www.youtube.com/c/drnashainc/videos?app=desktop For more information on the Metabolic Terrain Institute of Health: https://mtih.org Additional Resources from Dr. Nasha: Education Resources: https://www.drnasha.com/matcbook/ The Mistletoe Book: https://www.themistletoebook.com MTIH - Practitioner Terrain Network: https://terrain.network/tap/ Timestamps: 00:00 Understanding Cancer's Growing Impact 03:20 "Integrative Cancer Care: Bridging Worlds" 08:29 Toxicity, Microbiome, and Individual Sensitivity 10:55 Circadian Rhythm and Holistic Stressors 13:31 Diet's Impact on Metabolic Health 17:55 Inconsistent Blood Sugar Standards 22:12 "Reevaluating Diet Myths: Fat vs. Sugar" 24:47 Personalized Metabolic Health Strategies 28:21 Alternative Ketosis Methods Explored 32:28 Fertility Masterclass Invitation 35:00 Inaccuracies in Cell Line Studies 37:37 "Ketosis: Impact on Cancer & Epilepsy" 41:53 DIPG Support and Resource Hub 44:07 "Clinician's Corner: Join & Share" Speaker bio: Dr. Nasha Winters is a global healthcare authority and best-selling author in integrative cancer care and research consulting with physicians around the world. She has educated hundreds of professionals in the clinical use of mistletoe and has created robust educational programs for both healthcare institutions and the public on incorporating vetted integrative therapies in cancer care to enhance outcomes. She is currently focused on opening a comprehensive metabolic oncology hospital and research institute in the U.S. where the best that standard of care has to offer and the most advanced integrative therapies will be offered. This facility will be in a residential setting on a gorgeous campus against a backdrop of regenerative farming, EMF mitigation and retreat, as well as state of the art medical technology and data collection and evaluation to improve patient outcomes. Keywords: cancer treatment, metabolic health, integrative medicine, functional health, ketogenic diet, therapeutic ketosis, metabolic flexibility, terrain theory, epigenetics, toxins, microbiome, immune function, inflammation, angiogenesis, blood sugar, insulin resistance, lipid profile, fasting, intermittent fasting, circadian rhythm, stress management, mental health, spiritual wellness, pediatric cancer, nutritional therapies, alternative medicine, complementary medicine, oncology, laboratory testing, diet personalization Disclaimer: The views expressed in the RWS Clinician's Corner series are those of the individual speakers and interviewees, and do not necessarily reflect the views of Restorative Wellness Solutions, LLC. Restorative Wellness Solutions, LLC does not specifically endorse or approve of any of the information or opinions expressed in the RWS Clinician's Corner series. The information and opinions expressed in the RWS Clinician's Corner series are for educational purposes only and should not be construed as medical advice. If you have any medical concerns, please consult with a qualified healthcare professional. Restorative Wellness Solutions, LLC is not liable for any damages or injuries that may result from the use of the information or opinions expressed in the RWS Clinician's Corner series. By viewing or listening to this information, you agree to hold Restorative Wellness Solutions, LLC harmless from any and all claims, demands, and causes of action arising out of or in connection with your participation. Thank you for your understanding.
Podcast family, we are in process of an exciting rebrand! Dr. Chapa's Clinical Pearls will soon become our legacy show as we change names and channels to, "Dr. Chapa's OBGYN No Spin Podcast". This will allow us to better align with our mission. Listen in for details and FIND US, as Dr. Chapa's OBGYN No Spin Podcast!!
In this episode with Dr Andrea Mosler, we discuss some great clinical pearls when assessing and treating groin pain. We explore:Assessment tools to explore impairmentsCategorisation of groin related groin painBattery of tests for differential diagnosisTop tips for the objective examinationThis episode is closely tied to Andrea's Practical she did with us. With Practicals you can see exactly how top experts assess and treat specific conditions – so you can become a better clinician, faster.
Clinical Pearls from Dr. Dominic D'Agostino: Therapeutic Strategies and Clinical Success with the Ketogenic Diet For this week's episode of the Clinician's Corner, we're doing something differently. We have gone into the archives and pulled out clinical pearls from some of our favorite episodes, and we're starting today with one of our most popular interviews with Dr. Dominic D'Agostino - where we unpack the ketogenic diet in all its nuances. This interview first aired back in 2023, and the full interview can be viewed here. Clinical pearls we extracted from the original interview: When the ketogenic diet is best used clinically; when it's contraindicated; and how to structure it for best results What the latest research is telling us about therapeutic application of this protocol - from metabolic health to neurological considerations and cancer Exogenous ketones: when and how to use them The intricacies of macronutrient ratios and when/how to cycle in and out of ketosis Measurement: the best forms for tracking ketosis and other key biomarkers to monitor The Clinician's Corner is brought to you by Restorative Wellness Solutions. Follow us: https://www.instagram.com/restorativewellnesssolutions/ Connect with Dr. D'Agostino: Website: https://drdominicdagostino.com/ Instagram: https://www.instagram.com/dominic.dagostino.kt/ LinkedIn: https://www.linkedin.com/in/dominic-d-agostino-156014b/ Twitter: https://twitter.com/DominicDAgosti2 Learn more about the ketogenic diet here: https://ketonutrition.org/ Timestamps: 00:00 History and Uses of Ketogenic Diet 06:25 Liver's Role in Ketone Production 07:22 Preventing Kidney Stones on Keto 13:15 Ketogenic Diet Supplement Tips 14:58 Minimal Supplements for Ketogenic Diet 18:07 Misleading Marketing of 1,3-Butanediol 24:08 Advanced Hormone and Metabolomics Testing 27:20 Monitor Meds During Diet Changes Speaker bio: Dr. D'Agostino is a tenured Associate Professor at the University of South Florida (USF) Morsani College of Medicine in the Department of Molecular Pharmacology and Physiology. He teaches medical neuroscience, medical physiology, nutrition and neuropharmacology. He is also a Research Scientist at the Institute for Human and Machine Cognition (IHMC) to assist with their efforts towards optimizing the safety, health and resilience of the warfighter and astronaut. His primary research focuses on developing and testing nutritional and metabolic-based therapies for a variety of disease states and advancing the use of metabolic-based therapies into human clinical applications. Keywords: ketogenic diet, therapeutic ketosis, blood ketone levels, exogenous ketones, metabolic therapies, epilepsy, neuroprotection, anti-seizure strategy, type 2 diabetes, weight loss, cancer, muscle wasting, Parkinson's disease, Alzheimer's disease, migraines, polycystic ovary syndrome, psychiatric disorders, bipolar disorder, anxiety, autism, traumatic brain injury, non-alcoholic fatty liver disease, stroke, GLUT1 deficiency, carnitine supplementation, kidney stones, electrolyte balance, MCT oil, creatine monohydrate, caffeine and ketone production, comprehensive blood work Disclaimer: The views expressed in the RWS Clinician's Corner series are those of the individual speakers and interviewees, and do not necessarily reflect the views of Restorative Wellness Solutions, LLC. Restorative Wellness Solutions, LLC does not specifically endorse or approve of any of the information or opinions expressed in the RWS Clinician's Corner series. The information and opinions expressed in the RWS Clinician's Corner series are for educational purposes only and should not be construed as medical advice. If you have any medical concerns, please consult with a qualified healthcare professional. Restorative Wellness Solutions, LLC is not liable for any damages or injuries that may result from the use of the information or opinions expressed in the RWS Clinician's Corner series. By viewing or listening to this information, you agree to hold Restorative Wellness Solutions, LLC harmless from any and all claims, demands, and causes of action arising out of or in connection with your participation. Thank you for your understanding.
Today we give you our final discussion with Dr. Andrew Kiselica regarding aspects of neuropsychological test interpretation. In this conversation, we end with some clinical pearls about integrating knowledge of psychometrics and strategies for test interpretation into our clinical practice. Show notes are available at www.NavNeuro.com/169 _________________ If you'd like to support the show, here are a few easy ways: 1) Get CE credits for listening to select episodes: www.NavNeuro.com/INS 2) Tell your friends and colleagues about it 3) Subscribe (free) and leave an Apple Podcasts rating/review: www.NavNeuro.com/itunes 4) Check out our book Becoming a Neuropsychologist, and leave it an Amazon rating Thanks for listening, and join us next time as we continue to navigate the brain and behavior! [Note: This podcast and all linked content is intended for general educational purposes only and does not constitute the practice of psychology or any other professional healthcare advice and services. No professional relationship is formed between hosts and listeners. All content is to be used at listeners' own risk. Users should always seek appropriate medical and psychological care from their licensed healthcare provider.]
Dr. Hector Chapa is a practicing OBGYN who is involved in education at Texas A&M University's School of Medicine. He is also the host of a fun and engaging medical podcast, "Dr. Chapa's Clinical Pearls," that focuses on women's healthcare. In this episode, Dr. Chapa shares his path through medicine touching on the importance of passion in medicine and the shifting landscape of reproductive rights and access to care in Texas.
From mast cells and microplastics to bile acids and B1 - this episode is a clinical deep dive you won't want to miss. If you're a wellness practitioner who loves learning the why behind what's happening in your patients' bodies, you're going to love this one. In this solo episode, I'm recapping some of the most cutting-edge insights I gathered at a recent CellCore clinical conference - and trust me, this one's packed. We're talking about:
Summary In this session from the 2024 SF Derm Society Annual Meeting, Dr. Lindy Fox discusses the critical topic of angioinvasive fungal infections, particularly in immunosuppressed patients. This truncated session covers the clinical presentation, diagnostic challenges, and emerging resistance patterns in fungal infections. Dr. Fox emphasizes the importance of recognizing the signs of invasive fungal infections and the need for broad coverage in treatment, especially given the rising rates of antifungal resistance. The episode concludes with key takeaways for dermatologists and a reminder of the podcast's educational purpose. Takeaways - Angioinvasive fungal infections are a significant concern for immunosuppressed patients. - Acute respiratory infections can increase the risk of invasive fungal infections. - Candida auris is a new resistant strain to be aware of. - Differentiating fungal organisms on H and E is unreliable; cultures are essential. - Antifungal resistance is on the rise, impacting treatment options. - Voreconazole does not treat mucor, leading to potential breakthrough infections. - L. prolificans is pan-resistant and often fatal. - Morphology is crucial in guiding the differential diagnosis of fungal infections. - Sweet syndrome can mimic other conditions histologically. - The podcast aims to educate and is not a substitute for medical advice. Chapters 00:00 - Introduction to the Future of Dermatology Podcast 00:53 - Understanding Angioinvasive Fungal Infections 03:49 - Clinical Pearls for Diagnosing Fungal Infections 08:02 - Diagnostic Considerations in Fungal Infections 10:06 - Therapeutic Considerations and Resistance Patterns
Brace yourself! This week, we're learning about cerebral palsy from Dr. Matthew MacCarthy, who is both a pediatric physical medicine and rehabilitation (PM&R) specialist at Prisma Health in South Carolina AND a person with cerebral palsy. We're talking NICU, Botox, and puberty, so get ready to stretch your knowledge with a thoughtful approach to CP diagnosis and management.
In this episode, Diogo Gomes interviews internationally renowned physiotherapist and researcher Dr. Alison Grimaldi for a focused discussion on gluteal tendinopathy. They explore common myths and misconceptions surrounding the condition, clarify the current evidence base, and share valuable clinical insights for effective assessment and management. With a clear and practical approach, Dr. Grimaldi offers take-home messages that clinicians can immediately apply in practice. Whether you manage this condition regularly or are looking to refine your approach, this episode is a must-listen.
In this episode, we discuss the appropriate use of benzodiazepines, focusing on evidence-based indications and optimal medication selection. Did you know that alprazolam has unique properties that make it more addictive than other benzodiazepines? Faculty: Alexis Ritvo, M.D. Host: Richard Seeber, M.D. Learn more about our memberships here Earn 1 CME: Understanding Benzodiazepine Prescribing: A Clinician's Guide Appropriate Benzodiazepine Use: Indications and Optimal Selection
In this episode, Dr. Christine Schaffner shares key insights from her recent experience at the Desbio conference, highlighting the growing field of Quantum Coherence Medicine. She explores how homeopathy functions as an electromagnetic signature, the importance of integrating emotional and spiritual layers into healing, and offers clinical pearls from leading practitioners. Tune in to hear how community, seasonal rhythms, and innovative approaches are shaping the future of integrative medicine. For the full show notes please visit my website: www.drchristineschaffner.com/Episode283
We discuss the injuries sustained from smoke inhalation. Hosts: Sarah Fetterolf, MD Brian Gilberti, MD https://media.blubrry.com/coreem/content.blubrry.com/coreem/Smoke_Inhalation.mp3 Download Leave a Comment Tags: Environmental, Toxicology Show Notes Table of Contents 00:37 – Overview of Smoke Inhalation Injury 00:55 – Three Key Pathophysiologic Processes 01:41 – Physical Exam Findings to Watch For 02:12 – Airway Management and Early Intervention 03:23 – Carbon Monoxide Toxicity 04:24 – Workup and Initial Treatment of CO Poisoning 06:14 – Cyanide Toxicity 07:19 – Treatment Options for Cyanide Poisoning 09:12 – Take-Home Points and Clinical Pearls Physiological Effects of Smoke Inhalation: Thermal Injury: Direct upper airway damage from heated air or steam. Leads to swelling, inflammation, and possible airway obstruction. Chemical Irritation: Causes bronchospasm, mucus plugging, and inflammation in the lower airways. Increases capillary permeability, potentially causing pulmonary edema. Systemic Toxicity: Primarily involves carbon monoxide and cyanide poisoning.
Fresh off the heels of our immediate last episode, we bring you a perspective from the trenches! Sarah, a Clinical Pearls podcast family member, is a health professional who works with autistic individuals. Sarah has provided clear and evidence-based data which helps to explain the rise of autism in the US over the last decades. Our podcast community is Incredible! Her noted and data driven perspective are the core concepts highlighted in this episode. Listen in for details.
Clinical Pearls, Pain Pod edition: Pain Pearls Part 1 (of many)! A cornucopia of pain conundrums and potential solutions and/or tools to help mitigate. All here, nicely packaged, randomly, in one episode of the Pain Pod! One of many more to come, in a miniseries titled: “Pain Pearls”, only here on the Pain Pod! Come one, come all, to the Pain Pod!!! P.S. Want to contribute or hear about a pain pearl of your own? Message Pain Guy on www.painguy.us to directly reach Mark and have your voice heard! Pain Guy • www.painguy.us DVPRS (Pain Scale) • https://www.va.gov/PAINMANAGEMENT/docs/DVPRS_2slides_and_references.pdf Opioid Risk Screenings • www.opioidrisk.com 2022 CDC Opioid Guideline Update • Dowell D, Ragan KR, Jones CM, Baldwin GT, Chou R. CDC Clinical Practice Guideline for Prescribing Opioids for Pain — United States, 2022. MMWR Recomm Rep 2022;71(No. RR-3):1–95. Buprenorphine Induction Resources • Kampman K and Jarvis M. American Society of Addiction Medicine (ASAM) National Practice Guideline for the Use of Medications in the Treatment of Addiction Involving Opioid Use. J Addict Med. Sep-Oct 2015;9(5):358-67. • Ahmed, S. Bhivandkar S, et. al. Microinduction of Buprenorphine/Naloxone: A Review of the Literature. The American Journal on Addictions, 30: 305–315, 2021. • Privia A. Randhawa, Rupinder Brar and Seonaid Nolan. Buprenorphine–naloxone “microdosing”: an alternative induction approach for the treatment of opioid use disorder in the wake of North America's increasingly potent illicit drug market CMAJ January 20, 2020 192 (3) E73. MOUD Minimum Durations Study • Michael L. Dennis, Mark A. Foss, and Christy K. Scott. An Eight-Year Perspective on the Relationship Between the Duration of Abstinence and Other Aspects of Recovery. Evaluation Review 2007 31:6, 585-612
There are many challenges when it comes to operating on a post-hysterectomy patient, especially when they have endometriosis. In this episode of BackTable OBGYN, Dr. Emad Mikhail, an associate professor of OBGYN at the University of South Florida, discusses the intricacies of treating endometriosis after a hysterectomy. --- SYNPOSIS Dr. Mikhail shares his journey from medical school in Egypt to his current expertise in deep endometriosis surgery in Tampa, Florida. The conversation covers preoperative evaluation, the importance of understanding patient history, and surgical approaches for complex cases. He emphasizes the need for multidisciplinary collaboration, advanced imaging, and specialized surgical techniques to ensure optimal patient outcomes. --- TIMESTAMPS 00:00 - Introduction 05:52 - The Role of Hysterectomy in Endometriosis 08:58 - The Role of Ovaries in Endometriosis 11:12 - Surgical Techniques and Considerations 18:11 - Evaluating Deep Endometriosis 24:32 - Post-Hysterectomy Pain and Symptoms 31:26 - Surgical Approaches Post-Hysterectomy 39:49 - The Importance of Continuous Learning 43:09 - Scar Tissue vs. Lesion 51:47 - Comprehensive Preoperative Assessment 53:59 - Conclusion and Final Thoughts
More clinical pearls from ACP #IM2024, including emerging infectious diseases in the US (malaria, dengue, super gonorrhea, and a resurgence of syphilis), new C. diff treatments, coagulopathy and cirrhosis, fatty liver disease, HFpEF, peripheral arterial disease, Lp(a) and ApoB, CAR T-cells for autoimmune disease, SGLT2i for gout, and hematology updates. Paul and Watto are joined by Drs. Nora Taranto, Beth Garbitelli, and of course Chris “The Chiu Man” Chiu. Claim CME for this episode at curbsiders.vcuhealth.org! Patreon | Episodes | Subscribe | Spotify | YouTube | Newsletter | Contact | Swag! | CME Show Segments 00:00 Tropical Diseases: Resurgence of Malaria and Dengue Fever 03:44 Infectious Diseases: Syphilis Rates and New Treatments for C. diff 08:28 Coagulopathy and Cirrhosis: Managing Hemostasis and Portal Vein Thrombosis 11:34 Fatty Liver Disease: Risk Stratification and Treatment 14:59 Cardiology Updates: Cardiovascular Kidney Metabolic Syndrome 31:03 New Medications for Hypertension 32:54 Renal Denervation and Hypertension 33:51 Lp(a) Drugs and Their Potential 36:01 Peripheral Arterial Disease and Claudication 38:10 SGLT2 Inhibitors and Gout 41:50 APO-B and LDL Cholesterol 42:45 Secondary Hypogonadism and Head and Neck Radiation 45:30 VEXAS: A Genetic Autoimmune Condition 49:08 Obesity-Induced Leukocytosis 52:49 CAR T-Cell Therapy in Rheumatologic Diseases Credits Producers/Writers/Show Notes: Matthew Watto MD, FACP; Paul Williams MD, FACP, Nora Taranto MD, Chris Chiu MD, Beth Garbitelli MD CME, Cover Art: Beth Garbitelli MD Hosts: Matthew Watto MD, FACP; Paul Williams MD, FACP Reviewer: Nora Taranto MD Showrunners: Matthew Watto MD, FACP; Paul Williams MD, FACP Technical Production: PodPaste Sponsor: Litter Robot Go to stopscooping.com/CURB and enter promocode CURB to save an EXTRA $50 on any Litter-Robot bundle. Sponsor: Freed You can try Freed for free right now by going to freed.ai. And listeners of Curbsiders can use code CURB50 for $50 off their first month. Sponsor: Beginly Visit beginlyhealth.com/curbsiders for the job matching platform for every Physician and Advanced Practice Clinician, from training to practice
We cover angina, COPD-asthma overlap, home oxygen, colon cancer screening, cancer survivorship, tobacco cessation, e-cigarettes, step counts for health, new drugs, the RSV vaccine, addiction medicine, interstitial lung disease, APOL1-mediated kidney disease, testosterone therapy, antimicrobial resistance, office-based allergy testing and more! The Curbsiders review highlights, clinical pearls, and practice-changing updates from the American College of Physician Internal Medicine Meeting #IM2024! No CME for this episode due to rapid turnaround, but claim CME for most episodes at curbsiders.vcuhealth.org! Patreon | Episodes | Subscribe | Spotify | YouTube | Newsletter | Contact | Swag! | CME Show Segments Intro ACP Pearls Outro Credits Producers: Matthew Watto MD, FACP; Paul Williams MD, FACP, Molly Heublein MD, Nora Taranto MD, Chris Chiu MD, Rahul Ganatra MD MPH, Beth Garbitelli MD Show Notes: Matthew Watto MD, FACP; Paul Williams MD, FACP, Molly Heublein MD, Nora Taranto MD, Chris Chiu MD, Rahul Ganatra MD MPH, Beth Garbitelli MD Hosts: Matthew Watto MD, FACP; Paul Williams MD, FACP Reviewer:Matthew Watto MD FACP Showrunners: Matthew Watto MD, FACP; Paul Williams MD, FACP Technical Production: PodPaste Sponsor: Beginly Health Visit https://beginlyhealth.com/curbsiders for the job matching platform for every Physician and Advanced Practice Clinician, from training to practice Sponsor: Freed You can try Freed for free right now by going to freed.ai. And listeners of Curbsiders can use code CURB50 for $50 off their first month.
© 2020-2026 Ivy Podcast Discovery LLC
